nodes	percent_of_prediction	percent_of_DWPC	metapath
Vecuronium—ABCB1—colon cancer	0.953	1	CbGaD
Vecuronium—Muscle atrophy—Vincristine—colon cancer	0.00625	0.133	CcSEcCtD
Vecuronium—Paralysis—Vincristine—colon cancer	0.00212	0.0451	CcSEcCtD
Vecuronium—Respiratory failure—Vincristine—colon cancer	0.0015	0.0319	CcSEcCtD
Vecuronium—Rash erythematous—Capecitabine—colon cancer	0.00125	0.0266	CcSEcCtD
Vecuronium—Injection site pain—Capecitabine—colon cancer	0.00118	0.025	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Irinotecan—colon cancer	0.00108	0.0229	CcSEcCtD
Vecuronium—Paralysis—Methotrexate—colon cancer	0.00103	0.0219	CcSEcCtD
Vecuronium—Injection site reaction—Capecitabine—colon cancer	0.000954	0.0203	CcSEcCtD
Vecuronium—Muscular weakness—Vincristine—colon cancer	0.000943	0.02	CcSEcCtD
Vecuronium—Muscular weakness—Fluorouracil—colon cancer	0.000879	0.0187	CcSEcCtD
Vecuronium—Apnoea—Methotrexate—colon cancer	0.000843	0.0179	CcSEcCtD
Vecuronium—Respiratory failure—Methotrexate—colon cancer	0.000727	0.0155	CcSEcCtD
Vecuronium—Connective tissue disorder—Vincristine—colon cancer	0.000727	0.0155	CcSEcCtD
Vecuronium—Connective tissue disorder—Irinotecan—colon cancer	0.000708	0.015	CcSEcCtD
Vecuronium—Cardiac disorder—Vincristine—colon cancer	0.000686	0.0146	CcSEcCtD
Vecuronium—Face oedema—Capecitabine—colon cancer	0.000673	0.0143	CcSEcCtD
Vecuronium—Angiopathy—Vincristine—colon cancer	0.000671	0.0143	CcSEcCtD
Vecuronium—Flushing—Irinotecan—colon cancer	0.000668	0.0142	CcSEcCtD
Vecuronium—Cardiac disorder—Irinotecan—colon cancer	0.000668	0.0142	CcSEcCtD
Vecuronium—Mediastinal disorder—Vincristine—colon cancer	0.000666	0.0142	CcSEcCtD
Vecuronium—Angiopathy—Irinotecan—colon cancer	0.000653	0.0139	CcSEcCtD
Vecuronium—Immune system disorder—Irinotecan—colon cancer	0.00065	0.0138	CcSEcCtD
Vecuronium—Mediastinal disorder—Irinotecan—colon cancer	0.000649	0.0138	CcSEcCtD
Vecuronium—Muscular weakness—Capecitabine—colon cancer	0.000614	0.0131	CcSEcCtD
Vecuronium—Erythema—Fluorouracil—colon cancer	0.0006	0.0128	CcSEcCtD
Vecuronium—Bronchospasm—Capecitabine—colon cancer	0.000592	0.0126	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Methotrexate—colon cancer	0.000536	0.0114	CcSEcCtD
Vecuronium—Anaphylactic shock—Vincristine—colon cancer	0.000525	0.0112	CcSEcCtD
Vecuronium—Nervous system disorder—Vincristine—colon cancer	0.000515	0.011	CcSEcCtD
Vecuronium—Anaphylactic shock—Irinotecan—colon cancer	0.000512	0.0109	CcSEcCtD
Vecuronium—Shock—Irinotecan—colon cancer	0.000503	0.0107	CcSEcCtD
Vecuronium—Nervous system disorder—Irinotecan—colon cancer	0.000502	0.0107	CcSEcCtD
Vecuronium—Hypotension—Vincristine—colon cancer	0.000491	0.0104	CcSEcCtD
Vecuronium—Anaphylactic shock—Fluorouracil—colon cancer	0.00049	0.0104	CcSEcCtD
Vecuronium—Nervous system disorder—Fluorouracil—colon cancer	0.00048	0.0102	CcSEcCtD
Vecuronium—Tachycardia—Fluorouracil—colon cancer	0.000478	0.0102	CcSEcCtD
Vecuronium—Hypotension—Irinotecan—colon cancer	0.000478	0.0102	CcSEcCtD
Vecuronium—Connective tissue disorder—Capecitabine—colon cancer	0.000474	0.0101	CcSEcCtD
Vecuronium—Hypotension—Fluorouracil—colon cancer	0.000458	0.00974	CcSEcCtD
Vecuronium—Flushing—Capecitabine—colon cancer	0.000447	0.00951	CcSEcCtD
Vecuronium—Cardiac disorder—Capecitabine—colon cancer	0.000447	0.00951	CcSEcCtD
Vecuronium—Angiopathy—Capecitabine—colon cancer	0.000437	0.0093	CcSEcCtD
Vecuronium—Immune system disorder—Capecitabine—colon cancer	0.000435	0.00926	CcSEcCtD
Vecuronium—Mediastinal disorder—Capecitabine—colon cancer	0.000434	0.00924	CcSEcCtD
Vecuronium—Erythema—Capecitabine—colon cancer	0.00042	0.00892	CcSEcCtD
Vecuronium—Urticaria—Fluorouracil—colon cancer	0.000389	0.00828	CcSEcCtD
Vecuronium—Hypersensitivity—Vincristine—colon cancer	0.000387	0.00823	CcSEcCtD
Vecuronium—Hypersensitivity—Irinotecan—colon cancer	0.000377	0.00801	CcSEcCtD
Vecuronium—Hypersensitivity—Fluorouracil—colon cancer	0.000361	0.00768	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000355	0.00754	CcSEcCtD
Vecuronium—Shock—Capecitabine—colon cancer	0.000337	0.00716	CcSEcCtD
Vecuronium—Nervous system disorder—Capecitabine—colon cancer	0.000336	0.00714	CcSEcCtD
Vecuronium—Tachycardia—Capecitabine—colon cancer	0.000334	0.00711	CcSEcCtD
Vecuronium—Cardiac disorder—Methotrexate—colon cancer	0.000333	0.00708	CcSEcCtD
Vecuronium—Skin disorder—Capecitabine—colon cancer	0.000333	0.00707	CcSEcCtD
Vecuronium—Rash—Vincristine—colon cancer	0.000331	0.00704	CcSEcCtD
Vecuronium—Dermatitis—Vincristine—colon cancer	0.000331	0.00704	CcSEcCtD
Vecuronium—Angiopathy—Methotrexate—colon cancer	0.000325	0.00692	CcSEcCtD
Vecuronium—Immune system disorder—Methotrexate—colon cancer	0.000324	0.00689	CcSEcCtD
Vecuronium—Mediastinal disorder—Methotrexate—colon cancer	0.000323	0.00688	CcSEcCtD
Vecuronium—Rash—Irinotecan—colon cancer	0.000323	0.00686	CcSEcCtD
Vecuronium—Dermatitis—Irinotecan—colon cancer	0.000322	0.00685	CcSEcCtD
Vecuronium—Hypotension—Capecitabine—colon cancer	0.00032	0.0068	CcSEcCtD
Vecuronium—Erythema—Methotrexate—colon cancer	0.000312	0.00664	CcSEcCtD
Vecuronium—Rash—Fluorouracil—colon cancer	0.000309	0.00657	CcSEcCtD
Vecuronium—Dermatitis—Fluorouracil—colon cancer	0.000309	0.00656	CcSEcCtD
Vecuronium—Urticaria—Capecitabine—colon cancer	0.000272	0.00578	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000264	0.00561	CcSEcCtD
Vecuronium—Anaphylactic shock—Methotrexate—colon cancer	0.000255	0.00542	CcSEcCtD
Vecuronium—Hypersensitivity—Capecitabine—colon cancer	0.000252	0.00536	CcSEcCtD
Vecuronium—Nervous system disorder—Methotrexate—colon cancer	0.00025	0.00532	CcSEcCtD
Vecuronium—Skin disorder—Methotrexate—colon cancer	0.000248	0.00526	CcSEcCtD
Vecuronium—Hypotension—Methotrexate—colon cancer	0.000238	0.00506	CcSEcCtD
Vecuronium—Rash—Capecitabine—colon cancer	0.000216	0.00459	CcSEcCtD
Vecuronium—Dermatitis—Capecitabine—colon cancer	0.000216	0.00459	CcSEcCtD
Vecuronium—Urticaria—Methotrexate—colon cancer	0.000202	0.00431	CcSEcCtD
Vecuronium—Hypersensitivity—Methotrexate—colon cancer	0.000188	0.00399	CcSEcCtD
Vecuronium—Rash—Methotrexate—colon cancer	0.000161	0.00342	CcSEcCtD
Vecuronium—Dermatitis—Methotrexate—colon cancer	0.000161	0.00341	CcSEcCtD
